ROCAN advises Dermapharm on acquisition of Arkopharma

November 10, 2022
November 10, 2022
ROCAN advises Dermapharm on acquisition of Arkopharma

The drugspecialist Dermapharm will acquire Arkopharma, a French manufacturer of nutritional supplements and over-the-counter herbal medicines. The seller is the private equity investor Montagu.

 

MARTIUS Rechtsanwälte acted as lead counsel for Dermapharm in the transaction. ROCANadvised on merger control aspects. More about the transaction here.